Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings at 6 months ...
Six-month results from the REMAIN-1 trial showed that Fractyl Health Inc.’s Revita procedure cut post-GLP-1 weight regain by about 70% compared with a sham procedure in patients who discontinued ...
Fractyl Health and Bariendo Inc. have announced a collaboration to explore the integration of Fractyl's investigational Revita procedure as a weight maintenance solution for patients discontinuing GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results